The RP105/MD-1 complex: molecular signaling mechanisms and pathophysiological implications

J Leukoc Biol. 2017 Jan;101(1):183-192. doi: 10.1189/jlb.2VMR1215-582R. Epub 2016 Apr 11.

Abstract

Radioprotective 105 kDa (CD180) is an unusual TLR that lacks an intracellular Toll-IL-1R signaling domain and exhibits unconventional homodimerization behavior. Differential expression and functions of radioprotective 105 kDa have been associated with immune-mediated pathologies, including infection, chronic inflammation, and autoimmune disorders. Radioprotective 105 kDa activates macrophages and B cells independently of canonical TLR signaling. Current understanding of the functional consequences of radioprotective 105 kDa signaling in B cells, macrophages, and dendritic cells indicates overlapping, but also some apparent opposing, cell-specific roles for radioprotective 105 kDa in shaping cellular functions. This review compares interactions of radioprotective 105 kDa with its coreceptors, CD19, TLR4, and TLR2; integrates recent, novel findings on radioprotective 105 kDa-mediated molecular signaling mechanisms; and summarizes current understanding of its contributions to infectious, inflammatory, and autoimmune disease.

Keywords: B cells; autoimmunity; infection; inflammation; macrophages.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / metabolism*
  • Autoimmune Diseases / immunology*
  • Autoimmune Diseases / physiopathology*
  • B-Lymphocytes / immunology
  • Humans
  • Lymphocyte Activation / immunology
  • Signal Transduction*
  • Toll-Like Receptors / metabolism

Substances

  • Antigens, CD
  • Toll-Like Receptors